USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study

BACKGROUND AND AIMS: Patients with advanced liver fibrosis owing to chronic hepatitis C virus genotype 1 represent a difficult-to-treat group even if a protease inhibitor is added to pegylated interferon alpha and ribavirin. Therefore, only patients with a high chance of cure should be treated with...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Ther Clin Risk Manag
Autors principals: Frankova, Sona, Jirsa, Milan, Merta, Dusan, Neroldova, Magdalena, Urbanek, Petr, Senkerikova, Renata, Spicak, Julius, Sperl, Jan
Format: Artigo
Idioma:Inglês
Publicat: Dove Medical Press 2015
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4687952/
https://ncbi.nlm.nih.gov/pubmed/26719699
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/TCRM.S94010
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars